Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2023 Mar 8;13:3907. doi: 10.1038/s41598-023-29547-3

Persistent impacts of smoking on resting-state EEG in male chronic smokers and past-smokers with 20 years of abstinence

Hyeji Lee 1,4,#, Yoonji Jeon 2,#, Cheolin Yoo 3, HeeYoung Seon 1, Jiwon Park 1, Minho Hwang 1, Kwangyeol Baek 2,, Dongil Chung 1,
PMCID: PMC9995515  PMID: 36890138

Abstract

Smoking is a severe addictive health risk behavior and notorious for the high likelihood of relapse after attempted cessation. Such an addictive pattern in smoking has been associated with neurobiological changes in the brain. However, little is known whether the neural changes associated with chronic smoking persist after a long period of successful abstinence. To address this question, we examined resting state EEG (rsEEG) in chronic smokers who have been smoking for 20 years or more, past-smokers who have been successfully abstaining for 20 years or more, and never-smokers. Both current-smokers and past-smokers showed significantly decreased relative theta power than never-smokers, showcasing persistent effect of smoking on the brain. Other rsEEG features in alpha frequency band demonstrated distinctive patterns associated with active smoking, such that compared to never-smokers, only current-smokers, but not past-smokers, showed significantly higher relative power, EEG reactivity—power changes between eyes-closed and eyes-open conditions—, and coherence between channels. Furthermore, individual variabilities across these rsEEG biomarkers were accounted for by individuals’ self-reported smoking history and nicotine dependence in current- and past- smokers. These data suggest the persistent effect of smoking on the brain even after sustained remission for 20 years.

Subject terms: Addiction, Addiction

Introduction

Smoking is one of the most severe addictive behaviors with health risk and the leading cause of preventable death that accounts for more than 8 million deaths each year worldwide1. A distinctive characteristic observed in smokers is that a large proportion of individuals who attempt to quit, particularly the ones who already attempted before2, is highly likely to relapse3. Such an addictive pattern has been conceptualized as a “cycle of spiraling dysregulation” of the brain4, describing a spiraling path from sensitization of dopaminergic and serotonergic neurotransmission with repeated drug intakes to their counteradaptation at withdrawal. This conceptual notion is in line with experimentally observed neurobiological changes in the brain57 that account for the reason why individuals become addicted and why they are vulnerable to relapse. This perspective was corroborated by previous studies showing that cue-induced neural responses811 and smaller brain volume in smokers are associated with a high risk of relapse12. A natural question that follows is whether or not smoking has long-term effects on the brain. However, it still remains elusive whether these changes in the brain of smokers are persistent even after a long period of successful abstinence. To address this issue, both the impacts of chronic smoking and of long-term abstinence need to be examined from individuals who have different histories of lifetime smoking.

Previous studies showed that electroencephalography (EEG) can be used to capture neural characteristics in psychopathology13,14. Among various features in EEG, the differences in spontaneous and intrinsic brain activities measured under the resting state15 have been found useful in dissociating smokers from never-smokers, and in characterizing smokers’ abstinence1618 and craving severity19. Particularly, being a smoker or administrating nicotine has been typically associated with decreased EEG powers in delta or theta frequency bands20,21, but with increased powers in alpha band2224. Note that most studies focused on the impact of smoking (acute or chronic) or a brief nicotine deprivation. It is unclear whether the EEG characteristics associated with chronic smoking are persistent over lifetime or reversible to some extent after long-term sustained remission. The aim of the current study is to examine EEG characteristics in individuals who have different smoking profiles (e.g., chronic smoking vs. successful long-term abstinence) and distinguish persistent effects of smoking from potentially recoverable ones. Based on previous reports on EEG biomarkers associated with smoking, we hypothesized that resting state EEG (rsEEG) powers measured from chronic smokers, past-smokers, and never-smokers would reveal neural changes associated with chronic smoking apart from the changes unobservable in past-smokers, as if they are recovered with successful long-term abstinence.

To examine long-term effects of smoking and abstinence, we explored EEG coherence as an additional feature in EEG. Previous studies showed that individuals with substance dependence (e.g., nicotine25, cannabis26, alcohol27, and heroine28) or behavioral addiction (e.g., gaming disorder and internet addiction29) demonstrate altered EEG coherence. In a recent study, Prashad et al.26 reported EEG coherence patterns in cannabis users, and suggested a possibility of using EEG coherence as a biomarker for substance use disorders. Winterer et al.27 examined EEG coherence in long-term abstinent alcohol users and showed that an increase in EEG coherence may be a trait-like (i.e., irreversible or invariant) feature for substance abuse. Based on these previous reports, we expected EEG coherence to provide a useful measure for investigating both the long-term effects of smoking and abstinence.

Neurobiologically, it is known that chronic nicotine exposure increases the number of nicotinic acetylcholine receptors (nAChR) and reduces their functional sensitivity30,31. In a series of studies on the neurodegenerative changes in the brain (e.g., Alzheimer’s disease), alpha reactivity—relative reduction in alpha band EEG power during eyes-open compared to eyes-closed resting state—has been suggested as a biomarker of cholinergic system integrity3234. Specifically, a recent study suggested that individuals’ alpha reactivity levels are associated with their functional connectivity between the visual cortex and the nucleus basalis of Meynert (NBM)33, a brain region considered as the main source of cortical cholinergic innervation. Based on these findings, we expected that EEG patterns of chronic cigarette smoking may also reflect the alternations in the functional connectivity between the associated brain regions. Across various previous studies that examined the relationship between smoking and alpha rhythm EEG, the focus has been on the impact of acute nicotine administration or temporary deprivation16,17,22,23 and of cue-induced responses10,35. Here, based on previously reported neurobiological changes linked to chronic smoking, we hypothesized that alpha reactivity in addition to EEG power and coherence may reflect the effects of long-term smoking and abstinence on acetylcholine circuitry in the brain. To test this hypothesis, we took extra attention to rsEEG difference between the eye-closed vs. the eye-open conditions.

We analyzed rsEEG data from 20 chronic heavy smokers who had continued daily smoking at least for 20 years, 28 past-smokers who successfully stayed abstinent for 20 years, and 33 non-smoking controls (i.e., never-smokers) in the current study. If there exist persistent neural alterations associated with smoking, similar EEG activity patterns should be observed between smokers and past-smokers even if the latter group has been successful in staying abstinent for a very long period, whereas the patterns should be different from that of never-smokers. To further examine individual differences, we explored correlations between individuals’ EEG features (power, coherence, and alpha reactivity) and their smoking related self-report measures (e.g., cigarettes per day, nicotine dependence, and number of quit attempts).

Results

Smokers, past-smokers, and never-smokers were matched for all demographics but smoking-related measures

Participants across three groups were matched for age (F(2, 78) = 1.76, P = 0.18), gender (all male), education (χ2(8) = 14.37, P = 0.073), and income level (F(2, 78) = 0.37, P = 0.69; Table 1). Smokers and past-smokers were comparable in the average number of cigarettes that individuals smoked (or used to smoke) per day (t(38) = 0.90, P = 0.38) as well as the number of quit attempts (U = 142, P = 0.12). Smokers and past-smokers differed in other smoking-related characteristics. Compared with past-smokers, smokers initiated smoking at their earlier age (t(46) = − 2.95, P = 4.95e−03), smoked for more years (t(46) = 13.63, P = 9.07e−18), reported higher nicotine dependence (FTND: t(37) = 2.81, P = 0.0079), and exhibited higher craving at the time of the experiment (QSU-brief: t(37) = 4.46, P = 7.30e−05). Besides these basic demographic information and smoking-related measures, we also collected individuals’ self-report depression symptoms that may accompany their smoking history, and confirmed that all three groups showed comparable levels of depression (F(2, 78) = 0.35, P = 0.70). These results indicate that any group differences, if exist, can be attributed to differences in smoking status among groups rather than other comorbidities.

Table 1.

Demographic information and smoking measures.

Never-smoker (n = 33) Past-smoker (n = 28) Smoker (n = 20) Test statistics
Age (years) 53.09 ± 4.96 (45–64) 54.64 ± 6.48 (42–69) 56.30 ± 7.12 (42–66)

F(2, 78) = 1.76

P = 0.18

Educationa 3.67 ± 1.14 3.32 ± 1.12 3.00 ± 0.97

χ2(8) = 14.37

P = 0.073

Income levelb 3.15 ± 1.25 3.14 ± 1.41 2.85 ± 1.42

F(2, 78) = 0.37

P = 0.69

K-BDI-II

8.63 ± 6.89

(1–27)

9.96 ± 6.50

(2–29)

8.75 ± 6.27

(0–22)

F(2, 78) = 0.35

P = 0.71

Age of smoking initiation**

19.43 ± 1.32

(17–22)

18.10 ± 1.80

(15–22)

t(46) = –2.95

P = 0.0049

Years smoking***

10.21 ± 6.43

(0.5–20)

37.80 ± 7.54

(23–50)

t(46) = 13.63

P = 9.07e−18

Cigarettes per dayc

18.24 ± 9.05

(10–40)

20.53 ± 6.76

(9–30)

t(38) = − 0.90

P = 0.38

Quit attemptsc

2.11 ± 2.11

(1–10)

2.15 ± 1.04

(1–5)

U = 142.00

P = 0.12

Abstinence duration

24.84 ± 4.70 years

(20–36)

4.80 ± 6.28 days

(2–30)

FTND total**,c

3.15 ± 3.17

(0–10)

5.58 ± 2.09

(3–10)

t(37) = 2.81

P = 0.0079

QSU-brief***,c

10.80 ± 2.73

(10–22)

21.32 ± 10.17

(10–43)

t(37) = 4.46

P = 7.30e−05

Means ± SDs and the range ([min–max]) of each item are reported. K-BDI-II, Korean Version of Beck Depression Inventory, Second Edition61; FTND, Fagerström Test for Nicotine Dependence57,58; QSU-brief, brief Questionnaire of Smoking Urges59.

aAverage education where 1 =  ≤ middle school graduate, 2 = high school graduate, 3 = some university or community college graduate, 4 = Bachelor’s degree, 5 =  ≥ Postgraduate studies.

bAverage household monthly income where 1 =  ≤ $1800, 2 = $1800 to 3500, 3 = $3500 to 5300, 4 = $5300 to 7000, 5 = $7000 to 8800, and 6 =  ≥ $8800.

cQuit attempts data are missing from ten past-smokers, and cigarettes per day data are missing from one smoker and seven past-smokers. FTND and QSU-brief data are missing from one smoker and eight past-smokers; **P < 0.01, ***P < 0.001.

Low frequency band powers and alpha reactivity are associated with individuals’ smoking status and habits

To test whether EEG powers are associated with individuals’ chronic smoking and abstinence, relative spectral powers were calculated in each frequency band for each group of individuals. In the eyes-open condition, there was no significant group difference in EEG relative band powers. On the contrary, for the eyes-closed condition, significant group differences were found in theta and alpha bands (Kruskal–Wallis test, false discovery rate adjusted P (PFDR) < 0.05; Fig. 1). Specifically, relative theta band power was significantly lower in smokers compared with never-smokers in a widespread area including the channels from the frontal, central, parietal, and occipital regions (Fp1, F3, Fz, FT9, FC1, FC2, FC5, C3, C4, TP9, CP1, CP2, CP5, CP6, P3, P4, P7, P8, Pz, O1, O2, and Oz; P < 0.05, post-hoc Tukey’s test). Past-smokers also showed diminished relative theta band power, such that their theta band powers from the frontal and occipital regions (Fp1, F4, F7, F8, FT9, FC6, P4, O2, and Oz; P < 0.05 in post-hoc Tukey’s test) were significantly lower than that of never-smokers. No significant theta power differences were observed between smokers and past-smokers.

Figure 1.

Figure 1

Relative EEG band power (eyes-closed condition). (A) Each row illustrates the average relative band powers calculated in each group. (B) Statistical group differences in relative band powers were observed in theta and alpha bands, particularly between the Smoker and the Control groups. Specifically, never-smoker controls showed larger relative power in theta band compared to the smoker and past-smoker groups, while smaller power in alpha band than the smoker group. The channels that showed a significant group difference are marked with larger unfilled markers (PFDR < 0.05).

In relative alpha band power, significant group differences were largely observed between the smoker and never-smoker groups. Smokers exhibited higher alpha power compared with never-smokers in the central and occipital regions (Fz, FC1, C3, CP1, P3, P4, P8, Pz, O1, O2, and Oz; P < 0.05, post-hoc Tukey’s test). Alpha band power in past-smokers was comparable with that of both the other two groups in all regions, except in T8 channel where smokers showed higher power than past-smokers (P < 0.05, post-hoc Tukey’s test).

It is worth noting that group differences in low frequency powers (theta, alpha bands) associated with smoking status were only observed from the eyes-closed condition, and that such a discrepancy mirrors previous reports regarding alpha reactivity—power reduction at eyes-open compared to eyes-closed condition within a specific frequency band3234. To directly test our hypothesis about its relevance to chronic smoking, we examined group differences in alpha reactivity. As hypothesized, smokers’ alpha reactivity was significantly higher than that of never-smokers and past-smokers (Kruskal–Wallis test: PFDR < 0.05; Fig. 2). Post-hoc Tukey’s test revealed that smokers showed larger alpha reactivity than never-smokers in a broad area (FP1, F3, F4, F7, Fz, FC1, FC2, FC5, FC6, C3, C4, CP1, CP2, CP6, TP1, P3, P4, P8, Pz, O1, O2, and Oz; P < 0.05, post-hoc Tukey’s test). Moreover, a part of the increased alpha reactivity in smokers, observed from the central and parietal regions (FC5, FC1, C4, CP6, CP2, and P8; P < 0.05, post-hoc Tukey’s test), was significantly higher than that in past-smokers. For completeness, we also calculated EEG reactivity in other frequency bands. However, there was no significant reactivity difference in other frequency bands between groups.

Figure 2.

Figure 2

EEG reactivity between the eyes-closed and the eyes-open conditions. (A) Each row illustrates average EEG reactivity measures calculated in each group, for each frequency band. (B) Statistical group differences in EEG reactivity were observed in alpha band. Particularly, smokers showed larger alpha reactivity compared with past-smokers or non-smoking controls. The channels that showed a significant group difference are marked with larger unfilled markers (PFDR < 0.05).

We further examined whether these features in low frequency bands are associated with individuals’ smoking-related characteristics other than their smoking status. Across the two smoker groups (smokers and past-smokers), the amount of cigarette consumption, nicotine dependence, and the number of quit attempts were significantly correlated with the relative powers in the theta frequency band (Fig. 4). Particularly, individuals who smoked more number of cigarettes per day (Pearson’s correlation coefficient r = − 0.31, bootstrapped P = 0.033) or reported higher nicotine dependence (FTND: r = − 0.40, bootstrapped P = 0.002) showed lower theta band power, while individuals who had more attempts to quit smoking showed higher theta band power (r = 0.43, bootstrapped P = 0.033). In contrast, there was no significant association between relative alpha power or alpha reactivity and individuals’ smoking-related self-report measures. These results indicate that theta band powers measured from eyes-closed rsEEG not only reflect the persistent effect of smoking across current- and past-smokers, but also capture detailed individual differences in their nicotine dependence severity and smoking behaviors independent of their recency.

Figure 4.

Figure 4

Correlations between EEG features and individuals’ smoking-related characteristics. Pearson’s correlation coefficients were calculated to examine the association between EEG characteristics (relative EEG band powers and coherence) and individuals’ smoking history measures (cigarettes per day, FTND, and number of quit attempts). (A) Across smokers and past-smokers, individuals who have smoked more (or had smoked more in the past for past-smokers) showed lower theta band power, (B) but higher alpha coherence. (A) In addition, individuals who self-reported higher nicotine dependence (FTND score) showed lower theta band power, and who had more quit attempts showed higher theta power. Each dot represents an individual participant, and the color-coded lines are the regression line between the corresponding measures.

Note that nicotine dependence (measured by FTND) was significantly different between current- and past- smokers (Table 1), and thus, the correlation between the dependence and theta power (Fig. 4A) could potentially reflect the group difference. When each group was examined separately, past-smokers still showed a significant association between their nicotine dependence and theta power (r = − 0.47, bootstrapped P = 0.011). In current-smokers, the association was trending in the same direction, but statistically not significant (r = − 0.28, bootstrapped P = 0.29). These results suggest that individuals’ theta powers reflect both their nicotine dependence and smoking status.

Alpha coherence is associated with individuals’ smoking status and habits

To test whether EEG coherence is associated with smoking as observed in other substance use disorders, we examined group differences in alpha band coherence across every pairs of channels (Fig. 3A). As in the aforementioned patterns of EEG powers, significant group differences were observed from the coherence during the eyes-closed condition (Kruskal–Wallis test: PFDR < 0.05; Fig. 3). Specifically, smokers had significantly higher alpha band coherence compared to never-smokers, primarily at the channel pairs among the left frontal, left parietal, and occipital regions (Fig. 3B,C). Among the alpha band coherence in smokers, coherence between the left and right frontal regions was higher than corresponding coherence patterns in past-smokers (Fig. 3B,C). Coherence in past-smokers was largely comparable with that in never-smokers, except for a few pairs of channels between the left frontal and occipital regions (Fig. 3B,C). No significant group difference in alpha band coherence was found in the EEG recordings during the eye-open condition. For completeness, we also examined EEG coherence in other frequency bands for the eye-closed and eye-open conditions, albeit no significant group difference was observed.

Figure 3.

Figure 3

Group differences in alpha band coherence. (A) Alpha band coherence between EEG channels was calculated in each group. (B) Significant group differences in alpha band coherence were observed most distinctively between the Smoker and the Control groups. (C) For an illustrative purpose, all significant group differences in inter-channel coherences are depicted with three different thickness levels (PFDR < 0.05, 0.01, and 0.001).

We further examined correlations between individuals’ coherences and their smoking-related measures to test whether the increased coherences are associated with individuals’ smoking history and/or severity. Regardless of smoking status, individuals who smoked more number of cigarettes per day showed significantly higher alpha coherence (r = 0.39, bootstrapped P = 0.023; Fig. 4B), evidencing for the severity effect on individuals’ EEG. On the contrary, there was no significant evidence suggesting the associations between EEG coherence and other self-report measures (nicotine dependence, quit attempts, or years of smoking). Consistent with previous findings in individuals with problematic substance uses (e.g., alcohol)27, these coherence results suggest that chronic and intensive smoking may alter the brain’s functional connectivity, which in turn increases coherences in the rsEEG.

Discussion

The current study examined three groups of individuals with different smoking profiles and investigated the persistent (or nonpersistent) effects of smoking on the brain. Both current- and past- smokers showed lower theta band power in rsEEG than non-smoking controls during eye-closed condition, demonstrating that impacts of smoking persist even after 20 or more years of abstinence. On the contrary, EEG features in alpha frequency band (i.e., higher alpha band power, higher alpha reactivity, and higher alpha band coherence) distinguished smokers from never-smokers; these alpha band differences were not observed between past- and never- smokers. The EEG patterns observed in long-term abstainers suggest that smoking-related EEG alterations in alpha frequency band are recoverable to some extent after a sufficient period of abstinence. In addition to the group differences, individuals’ self-report smoking behaviors and dependence accounted for the individual differences in the theta band powers and alpha band coherence across current- and past- smokers. These results showcase neural impacts of smoking on rsEEG that not only reflect individuals’ current state (e.g., nicotine dependence) but also the history of smoking (e.g., daily cigarette consumption).

Supporting the widely accepted view of addiction as a brain disease5,36, long-term exposure to addictive substances, regardless of their legality, is known to trigger functional and structural changes in the brain37. Based on these neurobiological changes, pharmacological targeting38 and brain stimulation39 have been suggested as plausible treatments for reversing the impacts of addiction on the brain. To date, however, previous studies focused on either the impacts of brief abstinence or that of acute nicotine consumption40, and it still has not been directly examined whether the neural traces of individuals’ smoking history in the brain ever disappear even after a long period of successful abstinence (c.f., see Karama et al.41 for the impacts of smoking on cortical thickness suggested to be reversible with long-term cessation). The current study addresses this gap by examining past-smokers who smoked daily for at least half a year and stayed abstinent for 20 years or longer. Moreover, smokers were recruited from a group behavior therapy for smoking cessation, and all the participants in the smoker group were mandated to be free from the recent influence of nicotine at the time of experiment. These settings matched sobriety of the two smoking groups. Thus, the differences we report cannot be interpreted as results of instant satiety in the smoker group, but rather as patterns distinguishing the consequence of chronic smoking vs. long-term complete abstinence.

Previous studies reported that nicotine-deprived smokers compared to never-smokers or to non-deprived smokers showed reduced power in low frequency bands (i.e., delta and theta)20,24. In contrast to these results, another study that specifically examined rsEEG of non-deprived smokers observed a similar pattern of reduced low frequency power compared to that of non-daily smokers42. This finding suggested that the changes in rsEEG might not simply be reflecting a state of withdrawal, but also associated with categorical smoking status (e.g., daily smoker, nondaily smoker). As noted above, all participants in the current study were abstinent at the time of the experiment, and thus any observed differences could be attributed to individuals’ smoking history (e.g., severity, quit attempts, dependence) and status (e.g., current-, past-, and non- smoker). The persistent effect of smoking observed both in current- and past- smokers in the present study was consistent with previous results, such that theta band power in the frontal and occipital regions was lower in smokers than never-smokers. Beyond this group difference, these patterns were more distinctive in individuals who have (or had) smoked more number of cigarettes per day, had less quit attempts, and had higher nicotine dependence. These results suggest that reduced low frequency power is a neural marker reflecting both individuals’ smoking history and dependency, and that the ‘scar’ remains even after a very long abstinence.

In a neurobiological perspective, long-term nicotine exposure is known to induce upregulation of nicotinic acetylcholine receptors and their desensitization31,43,44. Such neurobiological impacts of smoking may underlie the changes in functional connectivity between cortical regions and the NBM33, and in turn changes in cortical activities and EEG signals (e.g., alpha reactivity)45. Previous reports pointed out that part of these chronic changes may be recoverable. Particularly, it was reported that nAChR availability returns to the level comparable to non-smokers with 6–12 weeks of abstinence46. Complementary to these results, current-smokers exhibited heightened alpha reactivity compared to never- or past- smokers, whereas, as observed from the power spectrum patterns, past-smokers showed alpha reactivity pattern comparable to never-smokers. These results may indicate that neural changes induced by chronic smoking are recovered through a long period of abstinence. Alternatively, the observed difference among groups may be reflecting transient changes induced by a short period of abstinence (5 days on average) in current-smokers rather than by chronic smoking per se.46 Future study may directly collect both EEG and metabolic imaging (e.g., single-photon emission computed tomography; SPECT) to confirm the neural mechanism of alpha reactivity in relation to plastic change in the acetylcholine circuitry.

Relatively little is known about the impacts of smoking on EEG coherence40. One previous study, while the sample size was small, reported a consistent pattern in alpha coherence, such that smokers showed higher coherence than age-matched never-smokers47. Our data replicate and expand this result. Current-smokers showed higher alpha coherence than never-smokers across the whole brain, and moreover, past-smokers still showed higher coherence compared with never-smokers between the occipital and left frontal/temporal regions. Most interestingly, such an alteration in alpha coherence was associated with the number of cigarettes individuals smoked a day, regardless of their smoking status; individuals who smoked the most cigarettes a day, even after 20 years of abstinence, showed the highest alpha coherence. These results support that not only can EEG coherence be used as a biomarker detecting substance use disorder (e.g., cannabis use26, internet addiction29), but also as a measure reflecting a trace of long-term substance uses (e.g., alcohol use27).

The current study has the following limitations. First, it is a cross-sectional study and thus, we cannot confirm whether the observed neural patterns (e.g., lower theta power) are indeed consequences of chronic substance use (or abstinence) or individuals’ traits that should get credits for making them more (or less) prone to substance abuse. Future study with longitudinal tracking of individuals’ substance use history in conjunction with their neural data may provide further insights about causal roles of their brain’s characteristics in initiation of substance dependence48 as well as in sustained remission49. Second, the current study only includes data from male participants, and thus leaves it untested whether the same EEG features can be used in characterizing female smokers. Previous studies suggested that female smokers have different smoking behavior50 and moreover, different nicotine metabolism51. Given these reports, it is reasonable to expect that female smokers may show different neural signatures along their chronic smoking and abstinence. Direct investigation about and comparison between smokers of all genders would further expand our understanding of why there is a higher percentage of male smokers in general52 and why some individuals succeed better at quitting. Third, current-smokers who participated in the current study were all in an unsatiated state. As noted above, this inclusion criterion was set intentionally to investigate the effects of smoking history and status, rather than the effect of acute nicotine satiety. However, we cannot overlook that the same nicotine abstinence may have differential impacts on different groups; acute abstinence of smokers is likely to trigger neural and behavioral withdrawal symptoms, which must not be present in abstinent past-smokers due to the significant duration of abstinence. Future studies should examine the impact of acute nicotine satiety (or deprivation) above and beyond the long-term effects of smoking (or abstinence).

To conclude, we investigated how chronic smoking and long-term sustained remission affect the resting state EEG activity. Our data show that the EEG biomarkers in chronic smokers can also be observed at a significant level in past-smokers with more than 20 years of sustained remission, which suggests long-lasting and potentially irreversible impacts of smoking. It has been already well known that smokers who attempt to quit are highly likely to relapse and there are various factors associated with their failures2,3. Most of these risk factors (e.g., nicotine dependence, social environment) predicted relapse within the first few months of quitting, but failed to predict why some individuals still relapse after a few years of abstinence53. Our findings provide a neural explanation why individuals who ever initiated smoking in a lifetime may have changes in their brain and show different neural responses to perceptual11 and social information54, and also might be at constant risk of further problem behavior55.

Methods

Participants

Twenty-five chronic smokers, 31 past-smokers, and 38 never-smokers were recruited for the current study. Chronic smokers were recruited from a one-week group behavior therapy for smoking cessation, organized at Ulsan University Hospital, and all the smokers have been smoking daily for at least 20 years (total cigarette consumption > 18 pack-years). The exclusion criteria included neurological or psychiatric disorder, traumatic brain injury, and current use of psychoactive substances other than nicotine, and were initially assessed at the sign-up interview for the current study. Only three out of 25 smokers who met the inclusion criteria were female, which reflects a large difference in smoking rate between male vs. female in South Korea56. Due to the limited number of female smoker subjects, we decided to focus our investigation to male population only and left it as a limitation in the present study (see “Discussion”). Two additional smokers were excluded due to large EEG artifacts (see “EEG analyses” for artifact definition). At study intake, all smoker participants were abstinent for at least 24 h and only five participants smoked 6.20 ± 5.63 cigarettes in last 48 h. Before the EEG measurement, participants’ abstinence was confirmed by the exhaled carbon monoxide (eCO) level of 3 ppm or below (Micro Smokerlyzer, Bedfont Scientific Ltd., Maidstone, Kent, UK; BMC-2000, Senko International Inc., Osan-si, Gyeonggi-do, Republic of Korea). Never-smokers and past-smokers were recruited from local community via online advertisements. Never-smokers were strictly defined as individuals who smoked < 5 cigarettes in their lifetime and had not smoked in last month. To examine the effect of chronic smoking that persist after a long period of abstinence, we set inclusion criteria for the past-smoker group as following: (1) regularly smoked 10 or more cigarettes per day at least for 6 months, and (2) has been ceased smoking for 20 years or more. As in the smoker group, none of past- or never- smokers met the following exclusion criteria: history of neurological disorder, psychiatric disorder, or traumatic brain injury, and current use of psychoactive substances. Past- and never- smokers were also confirmed that they showed eCO level of either 0 or 1 ppm. Three past-smokers and five never-smokers were excluded due to extreme EEG artifacts (see “EEG analyses” for artifact definition). After applying aforementioned exclusion/inclusion criteria, final sample included 20 smokers (age = 56.30 ± 6.93), 28 past-smokers (age = 54.64 ± 6.36), and 33 never-smokers (age = 53.09 ± 4.88). See Table 1 for additional demographic information and smoking histories. The current study and all the protocols were approved by the Institutional Review Board (IRB) of Ulsan University Hospital and Ulsan National Institute of Science and Technology (UNIST) (UNISTIRB-19-45-A). All research was performed in accordance with relevant guidelines and regulations, and all participants provided written informed consent following an explanation of study procedures.

Smoking history and clinical measures

Smokers and past-smokers completed a battery of self-report measures, assessing their smoking history, nicotine dependence, and craving for nicotine. Nicotine dependence was measured using the Fagerström Test for Nicotine Dependence (FTND)57,58, and craving for nicotine was measured using a brief, 10-item version of the Questionnaire of Smoking Urges (QSU-brief)59. Given a tight association between smoking cessation attempts and depression60, individuals’ depression symptoms were also measured using Korean version of Beck Depression Inventory, second edition (K-BDI-II)61.

EEG acquisition

The electroencephalogram (EEG) was digitized at a sampling frequency of 500 Hz, amplified using the actiCHamp system (Brain Products GmbH, Germany), and recorded from 31 Ag/AgCl electrodes mounted in a cap (actiCap, Brain Products GmbH, Germany). We used the Fz electrode as a reference and the FPz as a ground. Impedances of all electrodes were maintained at ≤ 5 kΩ. Resting state EEG was recorded for three minutes during eyes-open and three minutes during eyes-closed conditions. During the eyes-open condition, participants were instructed to fixate their eyes at a crosshair located at the center of the monitor.

EEG analyses

EEG data analysis was conducted using EEGLAB version 2020.0 (Swartz Center for Computational Neuroscience, University of California at San Diego, CA) and MATLAB R2019b (Mathworks Ltd., Natick, MA). Raw EEG data were first filtered using a bandpass filter between 1 and 50 Hz. We utilized ICA algorithm in EEGLAB to identify and correct for eye blinking, muscle activity, line noise, and motion-related artifacts. Then, EEG data were re-referenced using the Common Average Reference (CAR). The noise-free periods in the EEG recordings were selected by visual inspection and sliced into two-second epochs. Fast Fourier Transform (FFT) was applied to preprocessed EEG to calculate signal power of EEG, i.e., power spectra (µV2). Spectral powers of the epochs were calculated for five separate frequency bands: Delta (1–4 Hz), Theta (4–8 Hz), Alpha (8–13 Hz), Beta (13–30 Hz), and Gamma (30–50 Hz).

From the initial participant pool, 2 smokers, 3 past-smokers, and 5 never-smokers were excluded from further analysis due to excessive EEG artifacts (> 75 μV throughout the entire EEG or EEG spectral power deviated > 3 SD from the group mean in each condition). In the remaining participants, EEG data with the spectral power deviated > 3 SD from the group mean in a single condition (i.e., eyes-open or eyes-closed) were only excluded from the statistical analysis for the corresponding condition: 5 smokers, 6 past-smokers, and 3 never-smokers.

To examine impacts of smoking status among groups, we calculated relative spectral powers, alpha reactivity, and alpha band coherence. Relative spectral powers were calculated in the following steps. First, FFT was applied to each of two-second epochs, and their power spectra were calculated. Second, absolute spectral powers of five separate frequency bands (i.e., delta, theta, alpha, beta, and gamma) were calculated for each epoch. Third, to obtain average band powers for each individual, absolute spectral band powers were averaged across epochs. Fourth, relative spectral powers of each frequency band were defined as a ratio between the absolute power of the corresponding frequency band and the total sum of absolute power from 1 to 50 Hz. To examine alpha band reactivity, we calculated EEG band power changes between eyes-closed and eyes-open conditions as follows33:

EEGreactivity=EEGbandpowereyes-closed-EEGbandpowereyes-openEEGbandpowereyes-closed

According to this definition, individuals who show larger alpha power difference between eyes- open and closed conditions have larger EEG reactivity.

The alpha band coherence was defined as the magnitude-squared coherence of the two signals using Welch's mean-corrected periodogram62. Given the two stationary signals x and y, the magnitude-squared coherence is defined as follows:

Cxyf=Pxy(f)2PxxfPyy(f)

where Pxx(f) and Pyy(f) are the power spectral density of signals x and y, respectively, and Pxy(f) is the cross power spectral density of the two signals. The alpha band coherence was calculated between all pairs of EEG channels in alpha frequency band.

Statistical analyses

We conducted one-way analysis of variance (ANOVA) with post-hoc Tukey’s tests for comparing age, income levels, and self-report depression levels (K-BDI-II) among the groups, and used the chi-squared test for comparing education levels among the groups. To test whether smokers and past-smokers differed on their smoking behaviors and self-report attitude against nicotine (dependence and craving), we used independent sample t-tests and compared age of smoking initiation, years of smoking, average number of cigarettes smoked per day, nicotine dependence (FTND total score), and nicotine craving (QSU-brief score). Mann–Whitney U test was used in comparing number of quit attempts between smokers and past-smokers, because the data violated assumptions of normality. Group differences in EEG band powers, alpha reactivity, and alpha band coherence were evaluated using Kruskal–Wallis test, a non-parametric test equivalent to one-way ANOVA. In all tests comparing EEG features, significance level was set at p-value < 0.05 after controlling for False Discovery Rate (FDR) across 31 channels, and post-hoc Tukey’s tests were conducted for comparison between groups. To further examine the associations between EEG features and individuals’ smoking-related characteristics, we first calculated the average of each EEG feature for each individual and used them as an individual’s representative neural measure. Specifically for relative theta power, alpha power, and alpha band reactivity, we averaged the calculated feature measures across all 31 channels for each individual. For alpha band coherence, we averaged the lower triangle of the coherence matrix, given that coherence values are symmetric between the lower and upper triangles. We evaluated Pearson’s correlations between EEG features and individuals’ self-reported measures related to smoking (e.g., FTND, QSU-brief, number of cigarettes smoked per day). Nonparametric bootstrapping method was used to compute confidence intervals (number of the bootstrapped samples = 10,000).

Acknowledgements

This work was supported in part by UNIST internal funding (1.210046.01) and the National Research Foundation of Korea (NRF-2018R1D1A1B07043582 to Chung). K.B. was partly supported by the National Research Foundation of Korea (NRF-2021R1F1A1063968), Institute of Information & Communications Technology Planning & Evaluation (Grant No. 2020-0-01450, Artificial Intelligence Convergence Research Center [Pusan National University]), and Ministry of Education of South Korea (the BK21 Four program, Korean Southeast Center for the 4th Industrial Revolution Leader Education).

Author contributions

Conceptualization: D.C.; Methodology: H.L., Y.J., C.Y., K.B., and D.C.; Formal analysis: H.L., Y.J., and K.B.; Funding acquisition: K.B. and D.C.; Investigation: H.L., Y.J., H.S., J.P., M.H., K.B., and D.C.; Writing – original draft: H.L., Y.J., K.B., and D.C.; Writing – review and editing: H.L., Y.J., C.Y., H.S., J.P., M.H., K.B., and D.C.; Supervision: K.B. and D.C.

Data availability

The datasets generated during and analyzed during the current study are available at https://github.com/dongilchung/rsEEG-smoker.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Hyeji Lee and Yoonji Jeon.

Contributor Information

Kwangyeol Baek, Email: kbaek@pusan.ac.kr.

Dongil Chung, Email: dchung@unist.ac.kr.

References

  • 1.World Health Organization . WHO Report on the Global Tobacco Epidemic 2021: Addressing New and Emerging Products. World Health Organization; 2021. [Google Scholar]
  • 2.Zhou X, et al. Attempts to quit smoking and relapse: Factors associated with success or failure from the ATTEMPT cohort study. Addict. Behav. 2009;34:365–373. doi: 10.1016/j.addbeh.2008.11.013. [DOI] [PubMed] [Google Scholar]
  • 3.García-Rodríguez O, et al. Probability and predictors of relapse to smoking: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Drug Alcohol Depend. 2013;132:479–485. doi: 10.1016/j.drugalcdep.2013.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Koob GF, Le Moal M. Drug abuse: Hedonic homeostatic dysregulation. Science. 1997;278:52–58. doi: 10.1126/science.278.5335.52. [DOI] [PubMed] [Google Scholar]
  • 5.Leshner AI. Addiction is a brain disease, and it matters. Science. 1997;278:45–47. doi: 10.1126/science.278.5335.45. [DOI] [PubMed] [Google Scholar]
  • 6.Volkow ND, Li T-K. Drug addiction: The neurobiology of behaviour gone awry. Nat. Rev. Neurosci. 2004;5:963–970. doi: 10.1038/nrn1539. [DOI] [PubMed] [Google Scholar]
  • 7.Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 2011;12:652–669. doi: 10.1038/nrn3119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bu J, et al. Low-theta electroencephalography coherence predicts cigarette craving in nicotine addiction. Front. Psychiatry. 2019;10:296. doi: 10.3389/fpsyt.2019.00296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Claus ED, Blaine SK, Filbey FM, Mayer AR, Hutchison KE. Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology. 2013;38:2363–2372. doi: 10.1038/npp.2013.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Littel M, Franken IH, Van Strien JW. Changes in the electroencephalographic spectrum in response to smoking cues in smokers and ex-smokers. Neuropsychobiology. 2009;59:43–50. doi: 10.1159/000205517. [DOI] [PubMed] [Google Scholar]
  • 11.Neuhaus A, et al. Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology. 2006;186:191–200. doi: 10.1007/s00213-006-0366-7. [DOI] [PubMed] [Google Scholar]
  • 12.Sinha R. New findings on biological factors predicting addiction relapse vulnerability. Curr. Psychiatry Rep. 2011;13:398. doi: 10.1007/s11920-011-0224-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McLoughlin G, Makeig S, Tsuang MT. In search of biomarkers in psychiatry: EEG-based measures of brain function. Am. J. Med. Genet. B. 2014;165:111–121. doi: 10.1002/ajmg.b.32208. [DOI] [PubMed] [Google Scholar]
  • 14.Gloss D, Varma JK, Pringsheim T, Nuwer MR. Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2016;87:2375–2379. doi: 10.1212/WNL.0000000000003265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Raichle ME. The restless brain. Brain Connect. 2011;1:3–12. doi: 10.1089/brain.2011.0019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Domino EF, et al. Tobacco smoking produces widespread dominant brain wave alpha frequency increases. Int. J. Psychophysiol. 2009;74:192–198. doi: 10.1016/j.ijpsycho.2009.08.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Evans DE, Sutton SK, Oliver JA, Drobes DJ. Cortical activity differs during nicotine deprivation versus satiation in heavy smokers. Psychopharmacology. 2015;232:1879–1885. doi: 10.1007/s00213-014-3821-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gilbert DG, et al. Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine Tob. Res. 2004;6:249–267. doi: 10.1080/14622200410001676305. [DOI] [PubMed] [Google Scholar]
  • 19.Li X, et al. Delta coherence in resting-state EEG predicts the reduction in cigarette craving after hypnotic aversion suggestions. Sci. Rep. 2017;7:1–8. doi: 10.1038/s41598-017-01373-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Dong F, et al. Abnormal resting-state EEG power and impaired inhibition control in young smokers. Neurosci. Lett. 2021;761:136120. doi: 10.1016/j.neulet.2021.136120. [DOI] [PubMed] [Google Scholar]
  • 21.Rass O, Ahn W-Y, O’Donnell BF. Resting-state EEG, impulsiveness, and personality in daily and nondaily smokers. Clin. Neurophysiol. 2016;127:409–418. doi: 10.1016/j.clinph.2015.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fisher DJ, Daniels R, Jaworska N, Knobelsdorf A, Knott VJ. Effects of acute nicotine administration on resting EEG in nonsmokers. Exp. Clin. Psychopharmacol. 2012;20:71. doi: 10.1037/a0025221. [DOI] [PubMed] [Google Scholar]
  • 23.Domino EF, Shigeaki M. Effects of tobacco smoking on the topographic EEG I. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1994;18:879–889. doi: 10.1016/0278-5846(94)90104-X. [DOI] [PubMed] [Google Scholar]
  • 24.Knott VJ, Fisher DJ. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers. Exp. Clin. Psychopharmacol. 2007;15:368. doi: 10.1037/1064-1297.15.4.368. [DOI] [PubMed] [Google Scholar]
  • 25.Li X, et al. Delta coherence in resting-state EEG predicts the reduction in cigarette craving after hypnotic aversion suggestions. Sci. Rep. 2017;7:2430. doi: 10.1038/s41598-017-01373-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Prashad S, Dedrick ES, Filbey FM. Cannabis users exhibit increased cortical activation during resting state compared to non-users. Neuroimage. 2018;179:176–186. doi: 10.1016/j.neuroimage.2018.06.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Winterer G, et al. EEG phenotype in alcoholism: Increased coherence in the depressive subtype. Acta Psychiatr. Scand. 2003;108:51–60. doi: 10.1034/j.1600-0447.2003.00060.x. [DOI] [PubMed] [Google Scholar]
  • 28.Franken IH, Stam CJ, Hendriks VM, van den Brink W. Electroencephalographic power and coherence analyses suggest altered brain function in abstinent male heroin-dependent patients. Neuropsychobiology. 2004;49:105–110. doi: 10.1159/000076419. [DOI] [PubMed] [Google Scholar]
  • 29.Burleigh TL, Griffiths MD, Sumich A, Wang GY, Kuss DJ. Gaming disorder and internet addiction: A systematic review of resting-state EEG studies. Addict. Behav. 2020;107:106429. doi: 10.1016/j.addbeh.2020.106429. [DOI] [PubMed] [Google Scholar]
  • 30.Gentry C, Lukas R. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr. Drug Targets-CNS Neurol. Disord. 2002;1:359–385. doi: 10.2174/1568007023339184. [DOI] [PubMed] [Google Scholar]
  • 31.Jasinska AJ, Zorick T, Brody AL, Stein EA. Dual role of nicotine in addiction and cognition: A review of neuroimaging studies in humans. Neuropharmacology. 2014;84:111–122. doi: 10.1016/j.neuropharm.2013.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Schumacher J, et al. EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer’s disease. Alzheimer's Res. Ther. 2020;12:1–12. doi: 10.1186/s13195-020-00613-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wan L, et al. From eyes-closed to eyes-open: Role of cholinergic projections in EC-to-EO alpha reactivity revealed by combining EEG and MRI. Hum. Brain Mapp. 2019;40:566–577. doi: 10.1002/hbm.24395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Van der Hiele K, et al. EEG and MRI correlates of mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging. 2007;28:1322–1329. doi: 10.1016/j.neurobiolaging.2006.06.006. [DOI] [PubMed] [Google Scholar]
  • 35.Knott VJ, et al. Craving-induced EEG reactivity in smokers: Effects of mood induction, nicotine dependence and gender. Neuropsychobiology. 2008;58:187–199. doi: 10.1159/000201716. [DOI] [PubMed] [Google Scholar]
  • 36.Heilig M, et al. Addiction as a brain disease revised: Why it still matters, and the need for consilience. Neuropsychopharmacology. 2021;46:1715–1723. doi: 10.1038/s41386-020-00950-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Volkow ND, Morales M. The brain on drugs: From reward to addiction. Cell. 2015;162:712–725. doi: 10.1016/j.cell.2015.07.046. [DOI] [PubMed] [Google Scholar]
  • 38.Volkow ND, Boyle M. Neuroscience of addiction: Relevance to prevention and treatment. Am. J. Psychiatry. 2018;175:729–740. doi: 10.1176/appi.ajp.2018.17101174. [DOI] [PubMed] [Google Scholar]
  • 39.Salling MC, Martinez D. Brain stimulation in addiction. Neuropsychopharmacology. 2016;41:2798–2809. doi: 10.1038/npp.2016.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Liu Y, et al. Resting-state EEG, substance use and abstinence after chronic use: A systematic review. Clin. EEG Neurosci. 2022;53:344–366. doi: 10.1177/15500594221076347. [DOI] [PubMed] [Google Scholar]
  • 41.Karama S, et al. Cigarette smoking and thinning of the brain’s cortex. Mol. Psychiatry. 2015;20:778–785. doi: 10.1038/mp.2014.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Rass O, Ahn WY, O'Donnell BF. Resting-state EEG, impulsiveness, and personality in daily and nondaily smokers. Clin. Neurophysiol. 2016;127:409–418. doi: 10.1016/j.clinph.2015.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Laviolette SR, Van Der Kooy D. The neurobiology of nicotine addiction: Bridging the gap from molecules to behaviour. Nat. Rev. Neurosci. 2004;5:55–65. doi: 10.1038/nrn1298. [DOI] [PubMed] [Google Scholar]
  • 44.Govind AP, Vezina P, Green WN. Nicotine-induced upregulation of nicotinic receptors: Underlying mechanisms and relevance to nicotine addiction. Biochem. Pharmacol. 2009;78:756–765. doi: 10.1016/j.bcp.2009.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Simpraga S, et al. An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds. Clin. Neurophysiol. 2018;129:2325–2332. doi: 10.1016/j.clinph.2018.08.014. [DOI] [PubMed] [Google Scholar]
  • 46.Cosgrove KP, et al. β2-nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch. Gen. Psychiatry. 2009;66:666–676. doi: 10.1001/archgenpsychiatry.2009.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Knott VJ, Harr A. Aging, smoking and EEG coherence: A preliminary study. Clin. Electroencephalogr. 1997;28:236–244. doi: 10.1177/155005949702800409. [DOI] [PubMed] [Google Scholar]
  • 48.Skara S, Sussman S. A review of 25 long-term adolescent tobacco and other drug use prevention program evaluations. Prev. Med. 2003;37:451–474. doi: 10.1016/S0091-7435(03)00166-X. [DOI] [PubMed] [Google Scholar]
  • 49.Fleury M-J, et al. Remission from substance use disorders: A systematic review and meta-analysis. Drug Alcohol Depend. 2016;168:293–306. doi: 10.1016/j.drugalcdep.2016.08.625. [DOI] [PubMed] [Google Scholar]
  • 50.Allen AM, Scheuermann TS, Nollen N, Hatsukami D, Ahluwalia JS. Gender differences in smoking behavior and dependence motives among daily and nondaily smokers. Nicotine Tob. Res. 2015;18:1408–1413. doi: 10.1093/ntr/ntv138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P., III Female sex and oral contraceptive use accelerate nicotine metabolism. Clin. Pharmacol. Ther. 2006;79:480–488. doi: 10.1016/j.clpt.2006.01.008. [DOI] [PubMed] [Google Scholar]
  • 52.Higgins ST, et al. A literature review on prevalence of gender differences and intersections with other vulnerabilities to tobacco use in the United States, 2004–2014. Prev. Med. 2015;80:89–100. doi: 10.1016/j.ypmed.2015.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yong HH, Borland R, Cummings KM, Partos T. Do predictors of smoking relapse change as a function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia. Addiction. 2018;113:1295–1304. doi: 10.1111/add.14182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Chung D, Orloff MA, Lauharatanahirun N, Chiu PH, King-Casas B. Valuation of peers’ safe choices is associated with substance-naïveté in adolescents. Proc. Natl. Acad. Sci. USA. 2020;117:31729–31737. doi: 10.1073/pnas.1919111117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Tucker JS, Ellickson PL, Orlando M, Martino SC, Klein DJ. Substance use trajectories from early adolescence to emerging adulthood: A comparison of smoking, binge drinking, and marijuana use. J. Drug Issues. 2005;35:307–332. doi: 10.1177/002204260503500205. [DOI] [Google Scholar]
  • 56.Gunter R, Szeto E, Jeong S-H, Suh SA, Waters AJ. Cigarette smoking in South Korea: A narrative review. Korean J. Fam. Med. 2020;41:3. doi: 10.4082/kjfm.18.0015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ahn HK, et al. The reliability and validity of Korean version of questionnaire for nicotine dependence. J. Korean Acad. Fam. Med. 2002;23:999–1008. [Google Scholar]
  • 58.Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerström test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991;86:1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x. [DOI] [PubMed] [Google Scholar]
  • 59.Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res. 2001;3:7–16. doi: 10.1080/14622200020032051. [DOI] [PubMed] [Google Scholar]
  • 60.Glassman AH, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264:1546–1549. doi: 10.1001/jama.1990.03450120058029. [DOI] [PubMed] [Google Scholar]
  • 61.Yu B-K, Lee H-K, Lee K-S. Validation and factor structure of Korean version of the Beck Depression Inventory Second Edition (BDI-II): In a university student sample. Korean J. Biol. Psychiatry. 2011;18:126–133. [Google Scholar]
  • 62.Stoica P, Moses RL. Spectral Analysis of Signals. Pearson Prentice Hall; 2005. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated during and analyzed during the current study are available at https://github.com/dongilchung/rsEEG-smoker.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES